InGeNA welcomes our new partner CCRM

InGeNA is proud to partner with CCRM Australia to strengthen the ecosystem delivering precision medicine and advanced therapies for Australians.

At the heart of this partnership is a shared ambition: that every Australian has clarity about the right treatment at the right time, and equitable access to it.

Precision medicine and advanced therapies are inherently linked, relying on genomics, biomarkers and data to enable more targeted care. Together, they are transforming what is possible in healthcare, guiding more personalised treatment decisions and offering new options, such as cell and gene therapies, where few previously existed. Realising this potential depends on a more connected and coordinated ecosystem.

This partnership creates opportunities to align efforts, support shared initiatives and reduce fragmentation across key areas including regulatory pathways, clinical trials, investment, market access and manufacturing.

CCRM Australia is a not-for-profit organisation working to accelerate the development, translation and commercialisation of regenerative medicine and advanced therapies in Australia. Leveraging national and international partnerships, deep sector knowledge and commercial expertise, CCRM Australia supports emerging ventures and builds Australia’s sovereign capability in cell and gene therapy manufacturing, translational science and advanced biomanufacturing.

Learn more about CCRM’s services at www.ccrmaustralia.com.au.